ATL-962: AZM said its ALT-962 increased fecal fat levels in 3 German placebo-controlled Phase Ib trials in 140 healthy volunteers. AZM said the product was safe

Alizyme plc (LSE:AZM), Cambridge, U.K. Product: ATL-962 Business: Metabolic Therapeutic category: Metabolism Target: Secreted lipase Description: Inhibitor of intestinal lipase that decreases dieta...